Patent ID: 7601505
Filing Date: 2009-10-13
Classification: C12Q,G01N

Abstract:
1. A method for predicting the clinical outcome of a breast cancer patient, the method comprising: a) determining the level of expression of marker M708 in a patient sample, wherein the M708 marker is selected from the group consisting of a marker that is at least 95% identical to the entire sequence of SEQ ID NO:75 or a marker that is at least 95% identical to the entire sequence of SEQ ID NO:76; b) determining the level of expression of marker M708 in a sample from a control subject having a good clinical outcome; and c) comparing the level of expression of marker M708 in the patient sample and in the sample from the control subject; wherein a higher level of expression of marker M708 in the patient sample as compared to the expression level in the sample from the control subject predicts that the patient will have a poor clinical outcome.